COVID-19: Dexamethasone discovery carries treatment implications (IMAGE)

University of Virginia Health System

COVID-19: Dexamethasone discovery carries treatment implications

Caption

Lead researcher Wladek Minor, PhD, of the University of Virginia School of Medicine Department of Molecular Physiology and Biological Physics. His discovery suggests diabetes and other factors may reduce dexamethasone's potentially lifesaving effectiveness for patients with severe COVID-19.

Credit

Dan Addison | UVA Communications

Usage Restrictions

May be used to accompany news coverage of the dexamethasone discovery. All other uses require express written permission from UVA Health.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.